NCT04645953: A trial that was reported late by Alexza Pharmaceuticals, Inc.
This trial has reported, although it was 587 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04645953 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Staccato Granisetron (AZ-010) for the Acute Treatment of Moderate to Severe Cyclic Vomiting Syndrome |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 5, 2021 |
| Completion date | July 26, 2022 |
| Required reporting date | July 26, 2023, midnight |
| Actual reporting date | March 4, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 587 |